The 1 analysts offering 12-month price forecasts for BiondVax Pharmaceuticals Ltd have a median target of 7.00, with a high estimate of 7.00 and a low estimate of 7.00. The median estimate represents a +498.29% increase from the last price of 1.17.
The current consensus among 1 polled investment analysts is to Buy stock in BiondVax Pharmaceuticals Ltd. This rating has held steady since January, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.01
Reporting Date Aug 25
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.